Home » Topics » Regulatory

Regulatory
RSS

FDA approves expanded label for Betaseron; ABOVE trial explores increased dose and frequency

March 19, 2003

FDA approves first fusion inhibitor for HIV infection

March 17, 2003

Licensing activity update for Zindaclin

March 17, 2003

Low-dose Prempro approved by FDA

March 17, 2003

Levitra approved in E.U.

March 11, 2003

New indication for Arava recommended for approval

March 10, 2003

Lercanidipine 20 mg approved in Europe

March 7, 2003

Oral tazarotene completes phase III studies

March 7, 2003

Myoview approved for assessment of left ventricular function

March 6, 2003

Priority review granted for Arixtra sNDA

March 6, 2003

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.